动脉样硬化中的代谢重编程和细胞相互作用:从分子机制到治疗策略
Yu-Xin Liu1,2, Feng-Ming Guo1,2, Wen-Jun Qiu1,2
1Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan 430060, China.
Journal of cardiovascular development and disease
|October 28, 2025
概括
动脉样硬化涉及主要细胞 (如巨细胞) 的代谢变化. 了解这些代谢变化为这种炎症性疾病提供了新的治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 代谢性疾病研究研究
- 细胞病理生理学
背景情况:
- 动脉样硬化是一种系统性炎症性疾病,由内皮功能障碍和斑块积累驱动.
- 代谢失调和细胞重塑是动脉样硬化病原体的核心.
- 关键的细胞类型包括内皮细胞,血管光滑肌细胞 (VSMC) 和巨细胞.
研究的目的:
- 审查最近在动脉样硬化中主要细胞类型的代谢重编程方面的进展.
- 讨论通过代谢变化介导的细胞-细胞交叉.
- 强调对大动脉动脉样硬化的代谢重编程的治疗含义.
主要方法:
- 关于最近科学进展的文献综述.
- 在内皮细胞,VSMC和巨细胞中对代谢重编程的分析.
- 检查由新陈代谢影响的细胞间通信通路.
主要成果:
- 在动脉样硬化期间,内皮细胞,VSMC和巨细胞发生了显著的代谢重编程.
- 代谢变化介导这些细胞类型之间的交叉通话,影响疾病的进展.
- 准代谢途径为动脉样硬化提供了潜在的治疗策略.
结论:
- 代谢重编程是动脉样硬化的一个基本方面.
- 细胞间代谢交叉对疾病发展起着至关重要的作用.
- 有针对性的代谢干预措施显示出对大动脉动脉样硬化的精确治疗有前途.
相关概念视频
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Atherosclerosis I: Introduction
890
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
890
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Inflammation
61.6K
Overview
61.6K
Atherosclerosis IV: Nursing Management
361
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
361
Coronary Artery Disease II: Pathophysiology
360
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
360

